Ranking by Regions
United States
Canada
Mexico
Brazil
Chile
Germany
United Kingdom
France
Spain
Netherlands
Sweden
Italy
Switzerland
Poland
Finland
China
Japan
South Korea
Hong Kong
Singapore
Indonesia
India
Malaysia
Taiwan
Thailand
Australia
New Zealand
Israel
Saudi Arabia
Turkey
Russia
South AfricaRanking by categories
As of April 16, 2025, Atossa Therapeutics (ATOS) has a market cap of $80.512 million USD. According to our data, Atossa Therapeutics is ranked No.7729 in global market value.
| Year | Market Cap | %Change |
|---|---|---|
| Apr 16, 2025 | $80.51 M |
-31.92%
|
| Dec 31, 2024 | $0.12 B |
6.82%
|
| Dec 29, 2023 | $0.11 B |
66.04%
|
| Dec 30, 2022 | $66.67 M |
-66.88%
|
| Dec 31, 2021 | $0.20 B |
68.42%
|
| Dec 31, 2020 | $0.12 B |
-39.49%
|
| Dec 31, 2019 | $0.20 B |
53.92%
|
| Dec 31, 2018 | $0.13 B |
-67.31%
|
| Dec 29, 2017 | $0.39 B |
-81.56%
|
| Dec 30, 2016 | $2.13 B |
-70.62%
|
| Dec 31, 2015 | $7.25 B |
-77.62%
|
| Dec 31, 2014 | $32.38 B |
-38.36%
|
| Dec 31, 2013 | $52.53 B |
-40.51%
|
| Dec 31, 2012 | $88.31 B |
100%
|
| Name | Market Cap | Market cap difference | Regions |
|---|---|---|---|
 Gilead Sciences
GILD
|
$131.74 B |
-0.002 M
|
USA
|
 Pfizer
PFE
|
$127.27 B |
-0.003 M
|
USA
|
 Moderna
MRNA
|
$10.14 B |
-0.001 M
|
USA
|
 AstraZeneca
AZN
|
$210.42 B |
-0.005 M
|
UK
|
 Johnson & Johnson
JNJ
|
$370.20 B |
0.003 M
|
USA
|
 Merck
MRK
|
$197.26 B |
0.003 M
|
USA
|
 Bristol-Myers Squibb
BMY
|
$101.74 B |
-0.001 M
|
USA
|
 Amgen
AMGN
|
$158.77 B |
0.132 B
|
USA
|
 Eli Lilly
LLY
|
$679.94 B |
-0.022 M
|
USA
|
 Novartis
NVS
|
$217.12 B |
0.003 M
|
Switzerland
|
 Sanofi
SNY
|
$123.58 B |
-0.002 M
|
France
|
 GlaxoSmithKline
GSK
|
$72.33 B |
-0.002 M
|
UK
|
 Regeneron Pharmaceuticals
REGN
|
$60.99 B |
1.014 B
|
USA
|
 Biogen
BIIB
|
$17.12 B |
0.000 M
|
USA
|
| Market Cap | = | ATOS Stock Price | * | ATOS Shares Outstanding |
| = | $0.62 | * | 0.13 B | |
| = | $80.51 M |